Stock vs Stock Comparison

Centene Corporation vs Abbott Laboratories

ABT wins the Tale of the Tape 6–3.

CNC$59.55
ABT$86.99

🏆 Tale of the Tape

36
CNCABT
-3.4%Profitability (Net Margin)14.7%
Valuation (P/E)24.0x
-11.9%Efficiency (ROIC)10.1%
3/9Health (Piotroski F)5/9
2.7Safety (Altman Z)4.9
19.4%Growth (Rev YoY)5.7%
-0.54Risk (Sharpe 1Y)-1.05
2.83xBalance Sheet (D/E)0.64x
24.27%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.214
252-Day Correlation
0.204
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCNCABT
Market Cap$29.4B$149.1B
P/E Ratio24.0x
Forward P/E13.4x14.1x
P/B1.37x2.86x
Dividend Yield2.94%
Beta1.060.65

Quantitative Metrics

MetricCNCABT
DCF Fair Value$149.25$57.20
DCF Upside+298.3%-43.2%
Piotroski F3/95/9
Altman Z2.694.87
Beneish M-3.06-2.53
FCF Yield24.27%4.21%
Net Debt/EBITDA0.1x
ROIC-11.9%10.1%
WACC6.3%9.4%
ROIC – WACC-18.2pp0.7pp
Gross Margin7.1%56.4%
Net Margin-3.4%14.7%
Rev Growth YoY19.4%5.7%
Sharpe (1Y)-0.54-1.05
Max Drawdown 3Y
FCF Payout Ratio56%

CNC Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

CNC found in:

XHS2.90%
XLV0.50%
VHT0.43%
ONEV0.43%
VBR0.30%
VOE0.23%
VFVA0.22%
RSP0.22%
QUS0.19%
VB0.17%
VO0.13%
SPYV0.09%
VONV0.08%
SCHV0.07%
ONEO0.06%
IWD0.05%
VTV0.05%
SPY0.04%
SPTM0.04%
VOO0.04%
VTI0.04%
VONE0.04%
SCHX0.03%
IVV0.03%
SCHB0.03%
ESGV0.03%
SPLG0.03%
ITOT0.03%
URTH0.03%
ACWI0.02%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

CNC vs ABT: Head-to-Head Analysis

Centene Corporation (CNC) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABT leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, CNC generates a return on invested capital (ROIC) of -11.9% compared to ABT's 10.1%. This suggests ABT is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between CNC and ABT is 0.214, indicating low correlation, making them an effective diversification pair in a portfolio context.

CNC appears in 30 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, CNC or ABT?

Our quantitative analysis compares CNC and ABT across nine fundamental dimensions. ABT wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are CNC and ABT correlated?

The 252-day correlation between CNC and ABT is 0.214. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.